199 related articles for article (PubMed ID: 23400741)
1. Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil.
Lal R; Sukbuntherng J; Luo W; Tovera J; Lassauzet ML; Cundy KC
J Clin Pharmacol; 2013 Jan; 53(1):29-40. PubMed ID: 23400741
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.
Chen C; Upward J; Arumugham T; Stier B; Davy M
Clin Ther; 2015 Feb; 37(2):349-57. PubMed ID: 25467190
[TBL] [Abstract][Full Text] [Related]
7. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
Bogan RK; Lee DO; Buchfuhrer MJ; Jaros MJ; Kim R; Shang G
Ann Med; 2015 May; 47(3):269-77. PubMed ID: 25874578
[TBL] [Abstract][Full Text] [Related]
8. Gabapentin enacarbil for treatment of restless legs syndrome in adults.
Hayes WJ; Lemon MD; Farver DK
Ann Pharmacother; 2012 Feb; 46(2):229-39. PubMed ID: 22298601
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.
Lee DO; Buchfuhrer MJ; Garcia-Borreguero D; Avidan AY; Ahmed M; Hays R; Ondo WG; Jaros MJ; Kim R; Shang G
Sleep Med; 2016 Mar; 19():50-6. PubMed ID: 27198947
[TBL] [Abstract][Full Text] [Related]
12. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
VanMeter SA; Kavanagh ST; Warren S; Barrett RW
CNS Drugs; 2012 Sep; 26(9):773-80. PubMed ID: 22849331
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin.
Cundy KC; Sastry S; Luo W; Zou J; Moors TL; Canafax DM
J Clin Pharmacol; 2008 Dec; 48(12):1378-88. PubMed ID: 18827074
[TBL] [Abstract][Full Text] [Related]
14. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
[TBL] [Abstract][Full Text] [Related]
15. Gabapentin enacarbil: in patients with restless legs syndrome.
Scott LJ
CNS Drugs; 2012 Dec; 26(12):1073-83. PubMed ID: 23179641
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
Chen D; Lal R; Zomorodi K; Atluri H; Ho J; Luo W; Tovera J; Bonzo D; Cundy K
Clin Ther; 2012 Feb; 34(2):351-362.e3. PubMed ID: 22325733
[TBL] [Abstract][Full Text] [Related]
17. The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.
Lal R; Sukbuntherng J; Luo W; Huff FJ; Zou J; Cundy KC
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):120-8. PubMed ID: 20137764
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.
Lee DO; Ziman RB; Perkins AT; Poceta JS; Walters AS; Barrett RW;
J Clin Sleep Med; 2011 Jun; 7(3):282-92. PubMed ID: 21677899
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin Enacarbil: A Review in Restless Legs Syndrome.
Kim ES; Deeks ED
Drugs; 2016 May; 76(8):879-87. PubMed ID: 27146056
[TBL] [Abstract][Full Text] [Related]
20. Gabapentin enacarbil in restless legs syndrome.
Merlino G; Serafini A; Lorenzut S; Sommaro M; Gigli GL; Valente M
Drugs Today (Barc); 2010 Jan; 46(1):3-11. PubMed ID: 20200691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
